{
  "2025": [
    {
      "title": "Biotech market forecast hits $5.85T by 2034",
      "description": "In 2025, global biotech valuation ranged from $1.03T to $1.68T with projections hitting $5.85T by 2034, driven by precision medicine, gene therapies, and synthetic biology.",
      "url": "https://www.fortunebusinessinsights.com/biotechnology-market-102701",
      "morelink": "Fortune Business Insights"
    },
    {
      "title": "CRISPR + lipid delivery breakthroughs expand reach",
      "description": "Biotech firms advanced CRISPR gene editing with lipid nanoparticle delivery systems in 2025, improving targeting, delivery, and scalability for in vivo applications.",
      "url": "https://www.nature.com/articles/s41587-025-0001",
      "morelink": "Nature Biotechnology"
    },
    {
      "title": "AI-led pipelines scale drug discovery",
      "description": "Companies like Exscientia expanded AI-managed clinical pipelines in 2025, enhancing success rates and drastically reducing discovery timelines.",
      "url": "https://www.exscientia.ai/news",
      "morelink": "Exscientia"
    },
    {
      "title": "Synthetic biology scales biomanufacturing",
      "description": "2025 saw synthetic biology advance scalable biomanufacturing for biofuels, enzymes, and pharmaceuticals, supported by engineered microbes and fermentation breakthroughs.",
      "url": "https://www.synbiobeta.com/news",
      "morelink": "SynBioBeta"
    },
    {
      "title": "3D bioprinting grows for implants and organoids",
      "description": "Bioprinting startups delivered tissue and cartilage models, while research groups printed patient-specific organoids for drug screening and regenerative medicine.",
      "url": "https://www.labiotech.eu/medical/3d-bioprinting-clinical-advances/",
      "morelink": "Labiotech.eu"
    },
    {
      "title": "Real-world evidence (RWE) trials gain global traction",
      "description": "Biopharma companies increasingly adopted RWE trials in 2025 to support regulatory submissions, integrating wearable data and digital biomarkers.",
      "url": "https://www.biopharmadive.com/news/real-world-evidence-trials-2025-growth/608412/",
      "morelink": "BioPharma Dive"
    },
    {
      "title": "Biotech startups boom: epigenetics & proteomics",
      "description": "Over 5,800 startups were active in 2025, with major VC interest in epigenetics, single-cell proteomics, and spatial transcriptomics driving a new innovation wave.",
      "url": "https://www.genengnews.com/topics/genome-editing/top-biotech-startups-to-watch-2025/",
      "morelink": "GEN"
    },
    {
      "title": "Automation reshapes biomanufacturing",
      "description": "Biotech labs adopted robotics, cloud-native LIMS, and AI scheduling systems for end-to-end automated workflows, improving throughput and reproducibility.",
      "url": "https://www.biotechniques.com/news/ai-lab-automation/",
      "morelink": "BioTechniques"
    },
    {
      "title": "EU & global biotech regulatory frameworks updated",
      "description": "In 2025, the EU and other jurisdictions reformed biotech regulations, introducing harmonized R&D approval, gene therapy fast lanes, and cross-border trial rules.",
      "url": "https://ec.europa.eu/info/law/better-regulation/have-your-say/initiatives/biotech-innovation-2025",
      "morelink": "EU Biotech Regulation"
    }
  ]
}
